Shorts

0:57
Why Cervical Cancer Screening Shouldn't Stop at 65
a month ago
by
Noelle Gillette Cloven, MD

0:39
Recognizing Emotional Exhaustion in Burned-Out Colleagues
a month ago
by
Marcus Neubauer, MD

1:10
Personalizing Therapy After Iberdomide Approval in Myeloma
a month ago
by
Surbhi Sidana, MD

0:44
Why Oncology Needs Integrated AI Solutions
a month ago
by
Shaalan Beg, MD, MBA, FASCO

1:14
The Hidden Danger of Postsurgery Glioblastoma Regrowth
a month ago
by
Clark Chen, MD, PhD

0:49
Using AI to Bring Trials to More Patients
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:22
Your Wednesday Wrap-Up - August 26
2 months ago
by
Sabrina Serani

0:46
Balancing AI Efficiency With Human Oversight in Oncology
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:27
How Agentic AI Can Slash Clinical Trial Screening Time
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:50
Simplifying Chronic GVHD Screening for Physicians
2 months ago
by
Laila Alkhouli, MD

0:35
Helping Oncologists Cut Through the Data Overload
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:43
Agentic AI: Turning Fragmented Patient Data Into Clinical Trial Matches
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:49
Proactive Supportive Care Is Key With Bispecific Therapy
2 months ago
by
Natasha Edwin, MD

0:58
Why General-Purpose AI Doesn’t Cut It for Oncology
2 months ago
by
Shaalan Beg, MD, MBA, FASCO

0:35
Tocilizumab May Ease Bispecific Uptake in Community Practice
2 months ago
by
Natasha Edwin, MD

1:17
Navigating Early Treatment Access After Promising Trial Data
2 months ago
by
David Savage, MD, PhD

0:35
Your Wednesday Wrap-Up - August 19
2 months ago
by
Sabrina Serani

0:35
Why "Asian American" Isn't Just One Medical Category
2 months ago
by
Scarlett Lin Gomez, PhD, MPH

0:42
Targeting Breast Cancer's Nerve Connection
2 months ago
by
Jumana Abbadi, MD

0:32
A Surprising New Insight on How Breast Cancer Spreads
2 months ago

0:46
Can Operations Keep Pace With Oncology’s Outpatient Expansion?
2 months ago
by
Donna Berizzi, RN, DNP, OCN, NEA-BC

1:17
The Link Between Inflammation, Aging, and Cancer
2 months ago
by
Hearn Jay Cho, MD, PhD

0:34
An Often-Missed Early Step in Myeloma Care
2 months ago
by
Sagar Lonial, MD

0:17
Your Wednesday Wrap-Up - August 12th
2 months ago

0:34
Can We Cure Lung Cancer With Shorter Immunotherapy Treatment?
2 months ago
by
Ravi Salgia, MD, PhD

0:54
The Growing Case for ePROs in Community Oncology
2 months ago
by
Debra Patt, MD, PhD, MBA

0:50
Does ENDURANCE Support Lenalidomide Discontinuation At 2 Years?
2 months ago
by
Sagar Lonial, MD

0:41
OncoPRO Helps Practices Navigate ePRO Adoption
2 months ago
by
Debra Patt, MD, PhD, MBA

0:43
Can We Make Stage IV Lung Cancer Curable? New Research Offers Hope
2 months ago
by
Ravi Salgia, MD, PhD

0:36
ePRO Monitoring: Earlier Intervention, Fewer Hospitalizations
2 months ago
by
Debra Patt, MD, PhD, MBA
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Expanding the Role of Immunotherapy in Lymphoma
2
SurVaxM Improves OS Only in Younger Subgroup in Newly Diagnosed Glioblastoma
3
CLL Treatment Enters a New Era of Targeted Combinations
4
Psilocybin-Assisted Therapy Aims at Existential Distress in Lung Cancer
5
